Paratek's Omadacycline Get US Panel OK, But CABP Mortality Remains Concern

 
• By Derrick Gingery
  
Dart arrow hitting in the target center of dartboard using as background Target business, achieve and victory,success concept.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers